Lab marker | Demographic or disease activity marker | Pearson correlation coefficient | P values |
25OHD (ng/mL) | LL-37 (ng/mL) baseline | 0.04 | 0.58 |
25OHD (ng/mL) | PTH (pg/mL) baseline | −0.39 | < 0.01 |
LL-37 (ng/mL) | Daily corticosteroid dose (mg) | −0.06 | 0.44 |
LL-37 (ng/mL) | PTH (pg/mL) baseline | 0.07 | 0.30 |
PTH (pg/mL) | Age at randomisation (Years) | −0.10 | 0.14 |
PTH (pg/mL) | Body mass index (kg/m*m) | 0.04 | 0.60 |
PTH (pg/mL) | SLEDAI total | −0.01 | 0.93 |
PTH (pg/mL) | Mean—mean IMT common (mm) | 0.01 | 0.84 |
PTH (pg/mL) | Total cholesterol (mg/dL) | −0.13 | 0.06 |
PTH (pg/mL) | Triglycerides (mg/dL) | 0.01 | 0.99 |
PTH (pg/mL) | HDL cholesterol (mg/dL) | −0.11 | 0.11 |
PTH (pg/mL) | LDL cholesterol (mg/dL) | −0.11 | 0.13 |
PTH (pg/mL) | Lp(a) (mg/dL) | −0.12 | 0.03 |
PTH (pg/mL) | Homocysteine level (mcmol/L) | 0.01 | 0.90 |
PTH (pg/mL) | High sensitivity CRP (mg/L) | 0.03 | 0.65 |
PTH (pg/mL) | WCC | 0.00 | 0.96 |
Log of LL-37 (ng/mL) | Age at randomisation (Years) | 0.15 | 0.03 |
Log of LL-37 (ng/mL) | Body mass index (kg/m*m) | 0.10 | 0.16 |
Log of LL-37 (ng/mL) | SLEDAI total | −0.14 | 0.06 |
Log of LL-37 (ng/mL) | Mean—mean IMT common (mm) | 0.01 | 0.98 |
Log of LL-37 (ng/mL) | Total cholesterol (mg/dL) | −0.22 | < 0.01 |
Log of LL-37 (ng/mL) | Triglycerides (mg/dL) | −0.02 | 0.82 |
Log of LL-37 (ng/mL) | HDL cholesterol (mg/dL) | −0.19 | < 0.01 |
Log of LL-37 (ng/mL) | LDL cholesterol (mg/dL) | −0.19 | < 0.01 |
Log of LL-37 (ng/mL) | Lp(a) (mg/dL) | 0.02 | 0.83 |
Log of LL-37 (ng/mL) | Homocysteine level (mcmol/L) | −0.13 | 0.08 |
Log of LL-37 (ng/mL) | High sensitivity CRP (mg/L) | −0.02 | 0.76 |
Log of LL-37 (ng/mL) | WCC | 0.06 | 0.38 |
CRP, C-reactive protein; HDL, high-density lipoprotein; IMT, intima media thickness' LDL, low-density lipoprotein; LL-37, human cathelicidin; 25OHD, serum 25-hydroxyvitamin D; PTH, parathyroid hormone; SLEDAI, Systemic Lupus Eryrthematosus Disease Activity Index; WCC, white cell count.